Caldwell Sutter Capital »

Cadrenal Therapeutics shares owned by Caldwell Sutter Capital

Quarter-by-quarter ownership of Cadrenal Therapeutics shares owned by Caldwell Sutter Capital from 13F filings

Historical chart of Caldwell Sutter Capital investment in Cadrenal Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cadrenal Therapeutics held by Caldwell Sutter Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cadrenal Therapeutics by Caldwell Sutter Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $69 5 13.80
2025-06-30 $60 5 12.00
2025-03-31 $88 5 17.60

More positions owned by Caldwell Sutter Capital

Apple (AAPL)
Msa Safety Inc equity (MSA)
Perma-pipe International (PPIH)
Plumas Ban (PLBC)
Visa Com Cl A (V)
Donegal Group Cl A (DGICA)
Caterpillar (CAT)
Summit State Bank (SSBI)
Microsoft Corporation (MSFT)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Ishares Tr Core S&p500 Etf (IVV)
Kinetik Holdings New Cl A (KNTK)
Vanguard Specialized Funds Div App Etf (VIG)
JPMorgan Chase & Co. (JPM)
Costco Whsl Corp New Com (COST)

View all positions for Caldwell Sutter Capital

Top funds holding Cadrenal Therapeutics

Farther Finance Advisors
Carolina Wealth Advisors
Caldwell Sutter Capital

View all funds holding Cadrenal Therapeutics